Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1× · see citing works

Mitochondrial formation of reactive oxygen species

Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084 · see citing works

The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders

Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280 · see citing works

The blood-brain barrier/neurovascular unit in health and disease

Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661 · see citing works

Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line

Weksler, B. B., Subileau, E.-A., Perrière, N., Charneau, P., Holloway, K. E., Leveque, M., Tricoire-Leignel, H., Nicotra, A., Bourdoulous, S., Turowski, P., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3458fje · Cited by 1,325 · see citing works

Cerebral microvascular pathology in aging and Alzheimer's disease

Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102 · see citing works

Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE

Wautier, M., Chappey, O., Corda, S., Stern, D. M., Schmidt, A. M., & Wautier, J. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e685 · Cited by 1,076 · see citing works

An Assessment of Oxidative Damage to Proteins, Lipids, and DNA in Brain from Patients with Alzheimer's Disease

Lyras, L., Cairns, N. J., Jenner, A., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052061.x · Cited by 531 · see citing works

RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease

Donahue, J. E., Flaherty, S. L., Johanson, C. E., Duncan, J. A., Silverberg, G. D., Miller, M. C., Tavares, R., Yang, W., Wu, Q., Sabo, E., et al. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0115-3 · Cited by 519 · see citing works

Microvascular injury and blood–brain barrier leakage in Alzheimer's disease

Zipser, B. D., Johanson, C. E., Gonzalez, L., Berzin, T. M., Tavares, R., Hulette, C. M., Vitek, M. P., Hovanesian, V., & Stopa, E. G. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.016 · Cited by 487 · see citing works

NOX Enzymes in the Central Nervous System: From Signaling to Disease

Sorce, S., & Krause, K. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2578 · Cited by 472 · see citing works

Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease

Wang, J., Xiong, S., Xie, C., Markesbery, W. R., & Lovell, M. A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03053.x · Cited by 452 · see citing works

Two Types of Sporadic Cerebral Amyloid Angiopathy

Thal, D. R., Ghebremedhin, E., Rüb, U., Yamaguchi, H., Del Tredici, K., & Braak, H. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.3.282 · Cited by 446 · see citing works

Role of the Blood-Brain Barrier in the Pathogenesis of Alzheimers Disease

Deane, R., & Zloković, B. V. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362245 · Cited by 365 · see citing works

Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase and PKB signaling

Schreibelt, G., Kooij, G., Reijerkerk, A., van Doorn, R., Gringhuis, S. I., van der Pol, S., Weksler, B. B., Romero, I. A., Couraud, P., Piontek, J., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-8329com · Cited by 347 · see citing works

ROS Generation by Nonphagocytic NADPH Oxidase

Li, J., & Shah, A. M. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000077406.67663.e7 · Cited by 287 · see citing works

Reactive oxygen species mediate Rac-induced loss of cell-cell adhesion in primary human endothelial cells

van Wetering, S., van Buul, J. D., Quik, S., Mul, E. P. J., Anthony, E. C., ten Klooster, J. P., Collard, J. G., & Hordijk, P. L. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.9.1837 · Cited by 278 · see citing works

NADPH Oxidase-Derived Reactive Oxygen Species Mediate the Cerebrovascular Dysfunction Induced by the Amyloid β Peptide

Park, L., Anrather, J., Zhou, P., Frys, K., Pitstick, R., Younkin, S., Carlson, G. A., & Iadecola, C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5207-04.2005 · Cited by 244 · see citing works

A4 Protein in Alzheimer's Disease: Primary and Secondary Cellular Events in Extracellular Amyloid Deposition

Rozemüller, A. J. M., Eikelenboom, P., Stam, F. C., Beyreuther, K. T., & Masters, C. L. (1989) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198911000-00009 · Cited by 243 · see citing works

Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms

Attems, J. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1074-9 · Cited by 238 · see citing works

Oxidative Stress and Blood–Brain Barrier Dysfunction Under Particular Consideration of Matrix Metalloproteinases

Lehner, C., Gehwolf, R., Tempfer, H., Krizbai, I. A., Hennig, B., Bauer, H., & Bauer, H. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.3923 · Cited by 231 · see citing works

Ultrastructural features of the blood-brain barrier in biopsy tissue from Alzheimer's disease patients

Cláudio, L. (1995) · Acta Neuropathologica · doi:10.1007/s004010050386 · Cited by 210 · see citing works

The NADPH Oxidase of Endothelial Cells

BABIOR, B. M. (2000) · IUBMB Life · doi:10.1080/713803730 · Cited by 196 · see citing works

Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease

Zhu, X., Perry, G. L., Moreira, P. I., Aliev, G., Cash, A., Hirai, K., & Smith, M. A. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9207 · Cited by 195 · see citing works

Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review

Perlmutter, L. S., & Chui, H. C. (1990) · Brain Research Bulletin · doi:10.1016/0361-9230(90)90007-m · Cited by 193 · see citing works

Alzheimer’s disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy

Attems, J., Jellinger, K. A., & Lintner, F. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1064-y · Cited by 188 · see citing works

Tight Junctions in Brain Barriers During Central Nervous System Inflammation

Coisne, C., & Engelhardt, B. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.3929 · Cited by 186 · see citing works

Amyloid β‐Peptide Induces Cell Monolayer Albumin Permeability, Impairs Glucose Transport, and Induces Apoptosis in Vascular Endothelial Cells

Blanc, E. M., Toborek, M. J., Mark, R. J., Hennig, B., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68051870.x · Cited by 174 · see citing works

Amyloid β-peptide1–42 alters tight junction protein distribution and expression in brain microvessel endothelial cells

Marco, S., & Skaper, S. D. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.03.047 · Cited by 172 · see citing works

Thrombin accumulation in brains of patients with Alzheimer's disease

Akiyama, H., Ikeda, K., Kondo, H., & McGeer, P. L. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90065-f · Cited by 170 · see citing works

Pathogenesis of cerebral amyloid angiopathy

Rensink, A. A. M., de Waal, R. M. W., Kremer, B. P. H., & Verbeek, M. M. (2003) · Brain Research Reviews · doi:10.1016/j.brainresrev.2003.08.001 · Cited by 159 · see citing works

Thickening of the basement membrane of cortical capillaries in Alzheimer's disease

Mancardi, G., Perdelli, F., Rivano, C., Leonardi, A., & Bugiani, O. (1980) · Acta Neuropathologica · doi:10.1007/bf00692225 · Cited by 147 · see citing works

Occludin Protein Family: Oxidative Stress and Reducing Conditions

Blasig, I. E., Bellmann, C., Cording, J., Vecchio, G. D., Zwanziger, D., Huber, O., & Haseloff, R. F. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3542 · Cited by 139 · see citing works

The blood-brain barrier and cerebral microcirculation in Alzheimer disease.

Kalaria, R. N. (1992) · PubMed · Cited by 130 · see citing works

Claudins: Control of Barrier Function and Regulation in Response to Oxidant Stress

Overgaard, C. E., Daugherty, B. L., Mitchell, L. A., & Koval, M. H. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.3893 · Cited by 127 · see citing works

Melatonin impairs NADPH oxidase assembly and decreases superoxide anion production in microglia exposed to amyloid‐β1–42

Zhou, J., Zhang, S., Zhao, X., & Wei, T. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00570.x · Cited by 123 · see citing works

Amyloid-β-induced occludin down-regulation and increased permeability in human brain endothelial cells is mediated by MAPK activation

Tai, L. M., Holloway, K., Male, D. K., Loughlin, J., & Romero, I. A. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00717.x · Cited by 115 · see citing works

Insights into amyloid-β-induced mitochondrial dysfunction in Alzheimer disease

Wang, X., Su, B., Perry, G. L., Smith, M. A., & Zhu, X. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.09.007 · Cited by 102 · see citing works

Amyloid Angiopathy and Blood–Brain Barrier Changes in Alzheimer's Disease a, b

Wı́sniewski, H. M., VORBRODT, A. W., & WEGIEL, J. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48468.x · Cited by 99 · see citing works

Protective effect of erythropoietin on β-amyloid-induced PC12 cell death through antioxidant mechanisms

Li, G., Ma, R., Huang, C.-F., Tang, Q., Fu, Q., Liu, H., Hu, B., & Xiang, J. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.07.007 · Cited by 96 · see citing works

Characteristics of Dyshoric Capillary Cerebral Amyloid Angiopathy

Richard, E., Carrano, A., Hoozemans, J. J., van Horssen, J., van Haastert, E. S., Eurelings, L. S., de Vries, H. E., Thal, D. R., Eikelenboom, P., van Gool, W. A., et al. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181fab558 · Cited by 71 · see citing works

ZO Proteins and Redox-Dependent Processes

González‐Mariscal, L., Quirós, M., & Díaz-Coránguez, M. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.3913 · Cited by 66 · see citing works

Soluble aggregates of the amyloid‐β protein selectively stimulate permeability in human brain microvascular endothelial monolayers

Gonzalez‐Velasquez, F. J., Kotarek, J. A., & Moss, M. A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05618.x · Cited by 65 · see citing works

Ultrastructural Changes of Blood Vessels in the Cerebral Cortex in Alzheimer's Disease

Higuchi, Y., Miyakawa, T., Shimoji, A., & Katsuragi, S. (1987) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1987.tb00414.x · Cited by 37 · see citing works

Mitochondrial mechanisms in amyloid beta peptide-induced cerebrovascular degeneration

Hsu, M., Sheu, J., Lin, C., Shen, M., & Hsu, C. Y. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.08.003 · Cited by 34 · see citing works

Retinoic acid potentiated the protective effect of NGF against staurosporine-induced apoptosis in cultured chick neurons by increasing the trkA protein expression

Ahlemeyer, B., H�hne, R., & Krieglstein, J. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000615)60:6 · Cited by 34 · see citing works

The possible role of capillary cerebral amyloid angiopathy in Alzheimer lesion development: a regional comparison

Jeynes, B., & Provias, J. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0099-z · Cited by 31 · see citing works

Vascular Changes in the Brains with Alzheimer's Disease

Yamashita, K., Miyakawa, T., & Katsuragi, S. (1991) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1991.tb00509.x · Cited by 24 · see citing works

Amyloid beta toxicity dependent upon endothelial cell state

Balcells, M., Wallins, J. S., & Edelman, E. R. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.06.061 · Cited by 23 · see citing works

Cerebral Amyloid Angiopathy with Severe Secondary Vascular Pathology: A Histopathological Study

van Horssen, J., de Jong, D., de Waal, R. M. W., Maass, C., Otte‐Höller, I., Kremer, B. P. H., Verbeek, M. M., & Wesseling, P. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000088462 · Cited by 10 · see citing works

ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease

Simpson, D. S. A., & Oliver, P. L. (2020) · Antioxidants · doi:10.3390/antiox9080743 · Cited by 1,044 · see citing works

The blood-brain barrier in Alzheimer’s disease

Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767 · see citing works

Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease

Cai, Z., Hussain, M. D., & Yan, L.-J. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2013.833510 · Cited by 583 · see citing works

Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease

Erickson, M. A., & Banks, W. A. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.135 · Cited by 572 · see citing works

Markers of microglia in post-mortem brain samples from patients with Alzheimer’s disease: a systematic review

Hopperton, K. E., Mohammad, D., Trépanier, M. O., Giuliano, V, & Bazinet, R. P. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.246 · Cited by 567 · see citing works

Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer’s Disease

Yamazaki, Y., & Kanekiyo, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091965 · Cited by 451 · see citing works

Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders

Lochhead, J. J., Yang, J., Ronaldson, P. T., & Davis, T. P. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00914 · Cited by 445 · see citing works

NADPH oxidase in brain injury and neurodegenerative disorders

Ma, M. W., Wang, J., Zhang, Q., Wang, R., Dhandapani, K. M., Vadlamudi, R. K., & Brann, D. W. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0150-7 · Cited by 432 · see citing works

Factors controlling permeability of the blood–brain barrier

Almutairi, M. M., Chen, G., Xu, Y. G., Chang, Y., & Shi, H. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2050-8 · Cited by 308 · see citing works

Cerebrovascular disease in ageing and Alzheimer’s disease

Love, S., & Miners, J. S. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1522-0 · Cited by 299 · see citing works

Factors influencing the blood-brain barrier permeability

Zhao, Y., Gan, L., Ren, L., Lin, Y., Ma, C., & Lin, X. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147937 · Cited by 291 · see citing works

Cerebrovascular and blood–brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology

Drouin‐Ouellet, J., Sawiak, S. J., Cisbani, G., Lagacé, M., Kuan, W., Saint‐Pierre, M., Dury, R. J., Alata, W., St‐Amour, I., Mason, S. L., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24406 · Cited by 288 · see citing works

Oxidative stress and β-amyloid protein in Alzheimer’s disease

Cai, Z., Zhao, B., & Ratka, A. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8155-9 · Cited by 279 · see citing works

New Insights on <i>NOX</i> Enzymes in the Central Nervous System

Nayernia, Z., Jaquet, V., & Krause, K.-H. (2014) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2013.5703 · Cited by 279 · see citing works

Blood–Brain Barrier Dysfunction in a 3D In Vitro Model of Alzheimer's Disease

Shin, Y., Choi, S.-H., Kim, E., Bylykbashi, E., Kim, J. A., Chung, S., Kim, D. Y., Kamm, R., & Tanzi, R. (2019) · Advancement of science · doi:10.1002/advs.201900962 · Cited by 244 · see citing works

Blood–Brain Barrier Breakdown: An Emerging Biomarker of Cognitive Impairment in Normal Aging and Dementia

Hussain, B., Fang, C., & Chang, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.688090 · Cited by 251 · see citing works

Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders

Qosa, H., Miller, D. S., Pasinelli, P., & Trotti, D. (2015) · Brain Research · doi:10.1016/j.brainres.2015.07.005 · Cited by 249 · see citing works

Amyloid-β Contributes to Blood–Brain Barrier Leakage in Transgenic Human Amyloid Precursor Protein Mice and in Humans With Cerebral Amyloid Angiopathy

Hartz, A. M. S., Bauer, B., Soldner, E. L. B., Wolf, A., Boy, S., Backhaus, R., Mihaljevic, I., Bogdahn, U., Klünemann, H. H., Schuierer, G., et al. (2012) · Stroke · doi:10.1161/strokeaha.111.627562 · Cited by 248 · see citing works

Pathophysiology of RAGE in inflammatory diseases

Dong, H., Zhang, Y., Huang, Y., & Deng, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.931473 · Cited by 245 · see citing works

Oxidative Stress and Blood–Brain Barrier Dysfunction Under Particular Consideration of Matrix Metalloproteinases

Lehner, C., Gehwolf, R., Tempfer, H., Krizbai, I. A., Hennig, B., Bauer, H., & Bauer, H. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.3923 · Cited by 231 · see citing works

The blood–brain barrier

Obermeier, B., Verma, A., & Ransohoff, R. M. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63432-0.00003-7 · Cited by 210 · see citing works

Selective loss of cortical endothelial tight junction proteins during Alzheimer’s disease progression

Yamazaki, Y., Shinohara, M., Shinohara, M., Yamazaki, A., Murray, M. E., Liesinger, A. M., Heckman, M. G., Lesser, E. R., Parisi, J. E., Petersen, R. C., et al. (2019) · Brain · doi:10.1093/brain/awz011 · Cited by 202 · see citing works

The Relationship of Cerebral Vessel Pathology to Brain Microinfarcts

Arvanitakis, Z., Capuano, A. W., Leurgans, S. E., Buchman, A. S., Bennett, D. A. A., & Schneider, J. A. (2016) · Brain Pathology · doi:10.1111/bpa.12365 · Cited by 196 · see citing works

Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy

Blair, L. J., Frauen, H. D., Zhang, B., Nordhues, B. A., Bijan, S., Lin, Y.-C., Zamudio, F., Hernandez, L. D., Sabbagh, J. J., Selenica, M.-L. B., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0186-2 · Cited by 193 · see citing works

Mechanisms of Blood Brain Barrier Disruption by Different Types of Bacteria, and Bacterial–Host Interactions Facilitate the Bacterial Pathogen Invading the Brain

Al‐Obaidi, M. M. J., & Desa, M. N. M. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0609-2 · Cited by 189 · see citing works

Neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy

Carrano, A., Hoozemans, J. J. M., van der Vies, S. M., van Horssen, J., de Vries, H. E., & Rozemuller, A. J. M. (2012) · Neurodegenerative Diseases · doi:10.1159/000334916 · Cited by 186 · see citing works

NADPH Oxidases: From Molecular Mechanisms to Current Inhibitors

Cipriano, A., Viviano, M., Feoli, A., Milite, C., Sarno, G., Castellano, S., & Sbardella, G. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00770 · Cited by 190 · see citing works

Vascular cognitive impairment and dementia

Gorelick, P. B., Counts, S., & Nyenhuis, D. L. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.015 · Cited by 187 · see citing works

Dysfunction of the blood–brain barrier in Alzheimer's disease: Evidence from human studies

Kurz, C., Walker, L., Rauchmann, B., & Perneczky, R. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12782 · Cited by 183 · see citing works

Amyloid β Oligomers Disrupt Blood–CSF Barrier Integrity by Activating Matrix Metalloproteinases

Brkić, M., Balusu, S., Wonterghem, E. V., Gorlé, N., Benilova, I., Kremer, A., Hove, I. V., Moons, L., Strooper, B. D., Kanazir, S., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0006-15.2015 · Cited by 179 · see citing works

Oxidative Stress: A Major Player in Cerebrovascular Alterations Associated to Neurodegenerative Events

Carvalho, C., & Moreira, P. I. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00806 · Cited by 175 · see citing works

Vascular contributions to Alzheimer's disease

Eisenmenger, L. B., Peret, A., Famakin, B. M., Spahic, A., Roberts, G. S., Bockholt, J. H., Johnson, K. M., & Paulsen, J. S. (2022) · Translational research · doi:10.1016/j.trsl.2022.12.003 · Cited by 179 · see citing works

Blood-Brain Barrier Dysfunction in Normal Aging and Neurodegeneration: Mechanisms, Impact, and Treatments

Andjelkovic, A. V., Situ, M., Citalán‐Madrid, A. F., Stamatovic, S. M., Xiang, J., & Keep, R. F. (2023) · Stroke · doi:10.1161/strokeaha.122.040578 · Cited by 175 · see citing works

Oxidative stress and cerebral endothelial cells: Regulation of the blood–brain-barrier and antioxidant based interventions

Freeman, L. R., & Keller, J. N. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.12.009 · Cited by 173 · see citing works

Aβ1–42oligomer‐induced leakage in anin vitroblood–brain barrier model is associated with up‐regulation of RAGE and metalloproteinases, and down‐regulation of tight junction scaffold proteins

Wan, W., Cao, L., Liu, L., Zhang, C., Kalionis, B., Tai, X., Li, Y., & Xia, S. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13122 · Cited by 167 · see citing works

Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology

Nedić, O., Rattan, S. I. S., Grune, T., & Trougakos, I. P. (2013) · Free Radical Research · doi:10.3109/10715762.2013.806798 · Cited by 162 · see citing works

Autoregulated paracellular clearance of amyloid-β across the blood-brain barrier

Keaney, J., Walsh, D. M., O’Malley, T. T., Hudson, N., Crosbie, D. E., Loftus, T., Sheehan, F., McDaid, J., Humphries, M. M., Callanan, J. J., et al. (2015) · Science Advances · doi:10.1126/sciadv.1500472 · Cited by 148 · see citing works

Amyloid-β-dependent compromise of microvascular structure and function in a model of Alzheimer’s disease

Dorr, A. E., Sahota, B., Chinta, L. V., Brown, M. E., Lai, A. Y., Ma, K., Hawkes, C. A., McLaurin, J., & Stefanovic, B. (2012) · Brain · doi:10.1093/brain/aws243 · Cited by 153 · see citing works

Triggers and Effectors of Oxidative Stress at Blood-Brain Barrier Level: Relevance for Brain Ageing and Neurodegeneration

Enciu, A., Gherghiceanu, M., & Popescu, B. O. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/297512 · Cited by 150 · see citing works

Occludin Protein Family: Oxidative Stress and Reducing Conditions

Blasig, I. E., Bellmann, C., Cording, J., Vecchio, G. D., Zwanziger, D., Huber, O., & Haseloff, R. F. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3542 · Cited by 139 · see citing works

In Situ implantable, post-trauma microenvironment-responsive, ROS Depletion Hydrogels for the treatment of Traumatic brain injury

Qian, F., Han, Y., Han, Z., Zhang, D., Zhang, L., Zhao, G., Li, S., Jin, G., Yu, R., & Liu, H. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120675 · Cited by 137 · see citing works

Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics

Pan, Y., & Nicolazzo, J. A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.04.009 · Cited by 131 · see citing works

Effect of TTP488 in patients with mild to moderate Alzheimer’s disease

Burstein, A. H., Grimes, I., Galasko, D. R., Aisen, P. S. S., Sabbagh, M. N., & Mjalli, A. M. M. (2014) · BMC Neurology · doi:10.1186/1471-2377-14-12 · Cited by 137 · see citing works

Pathological changes within the cerebral vasculature in Alzheimer’s disease: New perspectives

Fisher, R. A., Miners, J. S., & Love, S. (2022) · Brain Pathology · doi:10.1111/bpa.13061 · Cited by 127 · see citing works

Wumei Wan attenuates angiogenesis and inflammation by modulating RAGE signaling pathway in IBD: Network pharmacology analysis and experimental evidence

Duan, Z., Wang, Y., Lü, Z., Tian, L., Xia, Z.-Q., Wang, K., Chen, T., Wang, R., Feng, Z.-Y., Shi, G., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154658 · Cited by 131 · see citing works

Innate immunity receptor CD36 promotes cerebral amyloid angiopathy

Park, L., Zhou, J., Zhou, P., Pistick, R., Jamal, S. E., Younkin, L. H., Pierce, J. P., Arreguin, A. J., Anrather, J., Younkin, S. G., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300021110 · Cited by 130 · see citing works

Salidroside attenuates beta amyloid-induced cognitive deficits via modulating oxidative stress and inflammatory mediators in rat hippocampus

Zhang, J., Zhen, Y., Pu-Bu-Ci-Ren, Song, L.-G., Kong, W.-N., Shao, T.-M., Li, X., & Xi-qing, C. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.037 · Cited by 129 · see citing works

Blood-brain barrier leakage in Alzheimer’s disease: From discovery to clinical relevance

Nehra, G., Bauer, B., & Hartz, A. M. S. (2022) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2022.108119 · Cited by 127 · see citing works

High-dose of vitamin C supplementation reduces amyloid plaque burden and ameliorates pathological changes in the brain of 5XFAD mice

Kook, S.-Y., Lee, K.-M., Kim, Y., Cha, M.-Y., Kang, S., Baik, S., Lee, H., Park, R., & Mook‐Jung, I. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.26 · Cited by 127 · see citing works

Astragaloside IV protects blood-brain barrier integrity from LPS-induced disruption via activating Nrf2 antioxidant signaling pathway in mice

Li, H., Wang, P., Huang, F., Jin, J., Wu, H., Zhang, B., Wang, Z., Shi, H., & Wu, X. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.12.019 · Cited by 125 · see citing works

Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier

van Doorn, R., Pinheiro, M. A. L., Kooij, G., Lakeman, K. A. M., Hof, B. V. H., van der Pol, S. M. A., Geerts, D., van Horssen, J., van der Valk, P., van der Kam, E. L., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-133 · Cited by 124 · see citing works

Claudins: Control of Barrier Function and Regulation in Response to Oxidant Stress

Overgaard, C. E., Daugherty, B. L., Mitchell, L. A., & Koval, M. H. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.3893 · Cited by 127 · see citing works

Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model

Jin, W., Shen, L., Bu, X., Zhang, W., Chen, S., Huang, Z., Xiong, J., Gao, C., Dong, Z., He, Y., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1721-y · Cited by 119 · see citing works

The blood brain barrier in Alzheimer’s disease

Chakraborty, A., de Wit, N. M., van der Flier, W. M., & de Vries, H. E. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2016.11.008 · Cited by 118 · see citing works

Insights into T‐cell dysfunction in Alzheimer's disease

Dai, L., & Shen, Y. (2021) · Aging Cell · doi:10.1111/acel.13511 · Cited by 119 · see citing works

The Blood–Brain Barrier, Oxidative Stress, and Insulin Resistance

Banks, W. A., & Rhea, E. M. (2021) · Antioxidants · doi:10.3390/antiox10111695 · Cited by 116 · see citing works

Inflammatory events at blood–brain barrier in neuroinflammatory and neurodegenerative disorders: Implications for clinical disease

de Vries, H. E., Kooij, G., Frenkel, D., Georgopoulos, S., Monsonego, A., & Janigro, D. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03702.x · Cited by 113 · see citing works

Blood-Brain Barrier: More Contributor to Disruption of Central Nervous System Homeostasis Than Victim in Neurological Disorders

Xiao, M., Xiao, Z. J., Yang, B., Lan, Z., & Fang, F. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00764 · Cited by 113 · see citing works

The role of neutrophil granule proteins in neuroinflammation and Alzheimer’s disease

Stock, A. J., Kasus‐Jacobi, A., & Pereira, H. A. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1284-4 · Cited by 114 · see citing works

Cytokine-mediated dysregulation of zonula occludens-1 properties in human brain microvascular endothelium

Rochfort, K. D., & Cummins, P. M. (2015) · Microvascular Research · doi:10.1016/j.mvr.2015.04.010 · Cited by 109 · see citing works

Oxidative stress, redox signalling and endothelial dysfunction in ageing‐related neurodegenerative diseases: a role of NADPH oxidase 2

Cahill‐Smith, S., & Li, J. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12357 · Cited by 106 · see citing works

Matrix Metalloproteinase in Blood-Brain Barrier Breakdown in Dementia

Weekman, E. M., & Wilcock, D. M. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150759 · Cited by 103 · see citing works

The role of the low-density lipoprotein receptor–related protein 1 (LRP-1) in regulating blood-brain barrier integrity

Zhao, Y., Li, Y., Zhao, J., Song, J., & Zhao, Y. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2015-0069 · Cited by 103 · see citing works

Cerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy?

Silva, T. M. D., & Miller, A. A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00061 · Cited by 104 · see citing works

BACE1: More than just a β‐secretase

Taylor, H. A., Przemyłska, L., Clavane, E. M., & Meakin, P. J. (2022) · Obesity Reviews · doi:10.1111/obr.13430 · Cited by 103 · see citing works

High-Density Lipoproteins and Cerebrovascular Integrity in Alzheimer’s Disease

Stukas, S. K., Robert, J., & Wellington, C. L. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.003 · Cited by 96 · see citing works

The Blood–Brain Barrier and Its Intercellular Junctions in Age-Related Brain Disorders

Costea, L., Mészáros, Á., Bauer, H., Bauer, H., Traweger, A., Wilhelm, I., Farkas, A. E., & Krizbai, I. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215472 · Cited by 98 · see citing works

Amyloid Fibrils Trigger the Release of Neutrophil Extracellular Traps (NETs), Causing Fibril Fragmentation by NET-associated Elastase

Azevedo, E. P., Guimarães-Costa, A. B., Torezani, G. S., Braga, C. A. C. A., Palhano, F. L., Kelly, J. W., Saraiva, E. M., & Foguel, D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.369942 · Cited by 97 · see citing works

The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier

Magaki, S., Tang, Z., Tung, S., Williams, C. K., Lo, D., Yong, W. H., Khanlou, N., & Vinters, H. V. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.004 · Cited by 93 · see citing works

Understanding the Pathophysiology of Cerebral Amyloid Angiopathy

Gatti, L., Tinelli, F., Scelzo, E., Arioli, F., Fede, G. D., Obici, L. P., Pantoni, L., Giaccone, G., Caroppo, P., Parati, E. A., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103435 · Cited by 94 · see citing works

Matrix Metalloproteinases in Alzheimer’s Disease and Concurrent Cerebral Microbleeds

Duits, F., Hernández-Guillamon, M., Montaner, J., Goos, J. D. C., Montañola, A., Wattjes, M., Barkhof, F., Scheltens, P., Teunissen, C., & van der Flier, W. M. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-143186 · Cited by 82 · see citing works

From Neurodevelopmental to Neurodegenerative Disorders: The Vascular Continuum

Ouellette, J., & Lacoste, B. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.749026 · Cited by 87 · see citing works

Inhibiting Ca2+ channels in Alzheimer’s disease model mice relaxes pericytes, improves cerebral blood flow and reduces immune cell stalling and hypoxia

Korte, N., Barkaway, A., Wells, J. A., Freitas, F., Sethi, H., Andrews, S. P., Skidmore, J., Stevens, B., & Attwell, D. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01753-w · Cited by 90 · see citing works

Neural stem cell therapy for neurovascular injury in Alzheimer's disease

Boese, A. C., Hamblin, M. H., & Lee, J. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113112 · Cited by 88 · see citing works

Sphingolipids in Alzheimer's disease, how can we target them?

Crivelli, S. M., Giovagnoni, C., Visseren, L., Scheithauer, A.-L., de Wit, N. M., den Hoedt, S., Losen, M. H., Mulder, M. T., Walter, J., de Vries, H. E., et al. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.12.003 · Cited by 85 · see citing works

Cerebrovascular disorders: molecular insights and therapeutic opportunities

Storkebaum, E., Quaegebeur, A., Vikkula, M., & Carmeliet, P. (2011) · Nature Neuroscience · doi:10.1038/nn.2947 · Cited by 86 · see citing works

Interactions between glial cells and the blood-brain barrier and their role in Alzheimer's disease

Zhao, M., Jiang, X., Zhang, H., Sun, J., Pei, H., Ma, L., Cao, Y., & Li, H. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101483 · Cited by 85 · see citing works

Limitations of the hCMEC/D3 cell line as a model for Aβ clearance by the human blood‐brain barrier

Biemans, E. A. L. M., Jäkel, L., de Waal, R. M. W., Kuiperij, H. B., & Verbeek, M. M. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23964 · Cited by 85 · see citing works

Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro

Harvey, B. S., Ohlsson, K. S., Mååg, J. L. V., Musgrave, I. F., & Smid, S. D. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2011.12.015 · Cited by 82 · see citing works

The blood–brain and gut–vascular barriers: from the perspective of claudins

Scalise, A. A., Kakogiannos, N., Zanardi, F., Iannelli, F., & Giannotta, M. (2021) · Tissue Barriers · doi:10.1080/21688370.2021.1926190 · Cited by 84 · see citing works

Antibody-Mediated Clearance of Brain Amyloid-β: Mechanisms of Action, Effects of Natural and Monoclonal Anti-Aβ Antibodies, and Downstream Effects

Loeffler, D. A. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230025 · Cited by 86 · see citing works

The potential mechanisms of Aβ-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer's disease

Wan, W., Chen, H., & Li, Y. (2013) · International Journal of Neuroscience · doi:10.3109/00207454.2013.825258 · Cited by 81 · see citing works

The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets

Qi, X.-M., & Ma, J. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0091-7 · Cited by 81 · see citing works

Microvascular NADPH oxidase in health and disease

Li, Y., & Pagano, P. J. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.02.049 · Cited by 79 · see citing works

The Blood–Brain Barrier: Composition, Properties, and Roles in Brain HealthPreprint

Lacoste, B., Prat, A., Andrade, M. F., & Gu, C. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041422 · Cited by 79 · see citing works

NADPH oxidase elevations in pyramidal neurons drive psychosocial stress-induced neuropathology

Schiavone, S., Jaquet, V., Sorce, S., Dubois‐Dauphin, M., Hultqvist, M. H., Bäckdahl, L., Holmdahl, R., Colaianna, M., Cuomo, V., Trabace, L., et al. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.36 · Cited by 75 · see citing works

Impairment of mitochondrial function by particulate matter: Implications for the brain

Chew, S., Kołosowska, N., Saveleva, L., Malm, T., & Kanninen, K. M. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104694 · Cited by 75 · see citing works

Neurovascular Alterations in Vascular Dementia: Emphasis on Risk Factors

Lecordier, S., Manrique‐Castano, D., Moghrabi, Y. E., & ElAli, A. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.727590 · Cited by 76 · see citing works

Vessel-Associated Immune Cells in Cerebrovascular Diseases: From Perivascular Macrophages to Vessel-Associated Microglia

Koizumi, T., Kerkhofs, D., Mizuno, T., Steinbusch, H. W. M., & Foulquier, S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01291 · Cited by 73 · see citing works

Establishing Co-Culture Blood–Brain Barrier Models for Different Neurodegeneration Conditions to Understand Its Effect on BBB Integrity

Park, J. S., Choe, K., Khan, A., Jo, M. H., Park, H. Y., Kang, M. H., Park, T. J., & Kim, M. O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065283 · Cited by 72 · see citing works

P‐glycoprotein (ABCB1) and Oxidative Stress: Focus on Alzheimer’s Disease

Sita, G., Hrelia, P., Tarozzi, A., & Morroni, F. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/7905486 · Cited by 72 · see citing works

Water-exchange MRI detects subtle blood-brain barrier breakdown in Alzheimer's disease rats

Dickie, B., Vandesquille, M., Ulloa, J. L., Boutin, H., Parkes, L. M., & Parker, G. J. M. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.09.030 · Cited by 71 · see citing works

Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer’s disease

Shi, H., Koronyo, Y., Fuchs, D.-T. S., Sheyn, J., Wawrowsky, K., Lahiri, S., Black, K. L., & Koronyo‐Hamaoui, M. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01076-4 · Cited by 70 · see citing works

Quercetin protects human brain microvascular endothelial cells from fibrillar β-amyloid1–40-induced toxicity

Li, Y., Zhou, S., Li, J., Sun, Y., Hamlati, H., Liu, R., & Zhang, T. (2015) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2014.12.003 · Cited by 70 · see citing works

Hyperglycemia Increases the Production of Amyloid Beta‐Peptide Leading to Decreased Endothelial Tight Junction

Chao, A., Lee, T.-Y., Juo, S. H., & Yang, D. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12503 · Cited by 67 · see citing works

Addressing Blood–Brain Barrier Impairment in Alzheimer’s Disease

Sharma, C., Woo, H., & Kim, S. R. (2022) · Biomedicines · doi:10.3390/biomedicines10040742 · Cited by 69 · see citing works

ZO Proteins and Redox-Dependent Processes

González‐Mariscal, L., Quirós, M., & Díaz-Coránguez, M. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.3913 · Cited by 66 · see citing works

B Cells in Neuroinflammation: New Perspectives and Mechanistic Insights

Ahn, J. J., Abu-Rub, M., & Miller, R. H. (2021) · Cells · doi:10.3390/cells10071605 · Cited by 65 · see citing works

Mechanobiology of the blood-brain barrier during development, disease and ageing

Konig, S., Jayarajan, V., Wray, S., Kamm, R. D., & Moeendarbary, E. (2025) · Nature Communications · doi:10.1038/s41467-025-61888-7 · Cited by 70 · see citing works

High-Throughput Screening for Identification of Blood-Brain Barrier Integrity Enhancers: A Drug Repurposing Opportunity to Rectify Vascular Amyloid Toxicity

Qosa, H., Mohamed, L. A., Rihani, S. B. A., Batarseh, Y. S., Duong, Q.-V., Keller, J. N., & Kaddoumi, A. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151179 · Cited by 62 · see citing works

P2‐263: Oxidative stress and tight junctions alterations in capillary cerebral amyloid angiopathy

Carrano, A., van Horssen, J., de Vries, H. E., & Rozemüller, A. J. M. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.05.1313

Neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy

Carrano, A., Hoozemans, J. J. M., van der Vies, S. M., van Horssen, J., de Vries, H. E., & Rozemuller, A. J. M. (2012) · Neurodegenerative Diseases · doi:10.1159/000334916 · Cited by 186 · see citing works

Amyloid Beta 25–35 induces blood-brain barrier disruption in vitro

Cuevas, E., Rosas-Hernández, H., Burks, S. M., Ramirez-Lee, M. A., Guzmán, A., Imam, S. Z., Ali, S. F., & Sarkar, S. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00447-8 · Cited by 57 · see citing works

Role of Aβ-receptor for advanced glycation endproducts interaction in oxidative stress and cytosolic phospholipase A2 activation in astrocytes and cerebral endothelial cells

Askarova, S., Yang, X., Sheng, W., Sun, G. Y., & Lee, J. C.-M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.038 · Cited by 92 · see citing works

Role of Aβ-RAGE interaction in oxidative stress and cPLA2 activation in astrocytes and cerebral endothelial cells

Askarova, S., Yang, X., Sheng, W., Sun, G. Y., & Lee, J. C. (2012) · Nazarbayev University Repository (Nazarbayev University)